Cargando…

Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?

Detalles Bibliográficos
Autor principal:	Polverino, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174170/ https://www.ncbi.nlm.nih.gov/pubmed/36753719 http://dx.doi.org/10.1165/rcmb.2022-0486ED

Ejemplares similares

Leveraging Omics to Predict Chronic Obstructive Pulmonary Disease Exacerbations: The “Immunome”
por: Polverino, Francesca, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis and coronary artery disease
por: Cicchitto, Gaetano, et al.
Publicado: (2014)

Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?
por: Polverino, Francesca
Publicado: (2019)

NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
por: Szema, Anthony M., et al.
Publicado: (2017)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

The ER Stress/UPR Axis in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
por: Aghaei, Mahmoud, et al.
Publicado: (2020)

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time
por: Calverley, Peter M. A., et al.
Publicado: (2019)

Asthma and Chronic Obstructive Pulmonary Disease: Just Old Friends or Relatives?
por: Polverino, Francesca, et al.
Publicado: (2021)

Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
por: Zhou, Yang, et al.
Publicado: (2010)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease
por: Lee, Jin Hwa, et al.
Publicado: (2014)

PRS-ing Forward to Identify Genetic Risk in Idiopathic Pulmonary Fibrosis
por: Blackwell, Timothy S., et al.
Publicado: (2023)

CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?
por: Racanelli, Alexandra C., et al.
Publicado: (2023)

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis
por: Leeming, Diana J., et al.
Publicado: (2012)

Non-coding RNAs as Regulators of Cellular Senescence in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
por: Omote, Norihito, et al.
Publicado: (2020)

Linking VEGF Deficiency and IL-33 Upregulation in Chronic Obstructive Pulmonary Disease
por: Byers, Derek E.
Publicado: (2019)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants
por: Moss, Benjamin J., et al.
Publicado: (2023)

Genetic Association Study Advances Idiopathic Pulmonary Fibrosis Pathophysiology and Health Equity
por: Hobbs, Brian D.
Publicado: (2022)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
por: Shi, Juan, et al.
Publicado: (2017)

Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
por: Ghosh, Auyon J., et al.
Publicado: (2022)

The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease
por: Knudsen, Kristel S., et al.
Publicado: (2022)

Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
por: Siddhuraj, Premkumar, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis and GERD: links and risks
por: Ghisa, Matteo, et al.
Publicado: (2019)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis Genetic Risk Factors, Function, and Mechanisms? The Concepts Are Starting to Gel
por: Bonham, Catherine A., et al.
Publicado: (2022)

Molecular genetics of idiopathic pulmonary fibrosis
por: Mustafin, R.N.
Publicado: (2022)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

Amerindian Ancestry Influences Genetic Susceptibility to Chronic Obstructive Pulmonary Disease
por: Díaz-Peña, Roberto, et al.
Publicado: (2020)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gfoukbls3o3a33lrd489jri82m